Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Vaccines
•
Allergy & Immunology
•
Primary Care
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Related Questions
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
What medications do you counsel patients to avoid if they develop ACEi angioedema?
What treatments do you consider for cholinergic urticaria refractory to high dose H1 blockers and omalizumab?
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
Do you continue shots when a patient transfers under your care and has been receiving less than effective doses of AIT, but insist they have been effective?
Under what circumstances would you recommend the maternal RSV vaccine for a pregnant patient if nirsevimab will also be available for the infant after birth?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
